Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 281.55
+2.20 (0.79%)
Sep 18, 2026, 4:59 PM CET
Novo Nordisk Ratios and Metrics
Market cap in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,245,255 | 1,445,242 | 2,772,285 | 3,112,331 | 2,118,803 | 1,674,992 | |
Market Cap Growth | -24.16% | -47.87% | -10.93% | 46.89% | 26.50% | 69.77% |
Enterprise Value | 1,340,400 | 1,513,873 | 2,754,376 | 3,091,273 | 2,107,299 | 1,653,350 |
Last Close Price | 281.55 | 310.45 | 579.24 | 640.70 | 425.04 | 328.13 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.75 | 14.11 | 27.45 | 37.19 | 38.16 | 35.07 |
Forward PE | 14.31 | 13.73 | 23.68 | 32.62 | 40.03 | 34.03 |
PS Ratio | 3.78 | 4.68 | 9.55 | 13.40 | 11.97 | 11.90 |
PB Ratio | 5.63 | 7.45 | 19.32 | 29.21 | 25.38 | 23.68 |
P/TBV Ratio | 12.55 | 22.58 | 84.87 | 67.43 | 65.10 | 60.74 |
P/FCF Ratio | 16.42 | 24.51 | 37.56 | 37.45 | 31.75 | 34.42 |
P/OCF Ratio | 9.44 | 12.13 | 22.92 | 28.58 | 26.86 | 30.45 |
PEG Ratio | 6.36 | 1.60 | 1.23 | 1.74 | 2.45 | 3.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.07 | 4.90 | 9.49 | 13.31 | 11.91 | 11.74 |
EV/EBITDA Ratio | 7.64 | 9.88 | 18.91 | 27.92 | 25.98 | 25.93 |
EV/EBIT Ratio | 8.31 | 10.77 | 19.83 | 29.53 | 27.87 | 27.92 |
EV/FCF Ratio | 17.67 | 25.68 | 37.32 | 37.20 | 31.57 | 33.97 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.63 | 0.68 | 0.72 | 0.25 | 0.31 | 0.38 |
Debt / EBITDA Ratio | 0.80 | 0.85 | 0.70 | 0.24 | 0.31 | 0.41 |
Debt / FCF Ratio | 1.85 | 2.22 | 1.39 | 0.33 | 0.39 | 0.55 |
Net Debt / Equity Ratio | 0.43 | 0.54 | 0.53 | -0.03 | 0.03 | 0.13 |
Net Debt / EBITDA Ratio | 0.55 | 0.68 | 0.53 | -0.03 | 0.03 | 0.14 |
Net Debt / FCF Ratio | 1.25 | 1.76 | 1.04 | -0.04 | 0.03 | 0.19 |
Asset Turnover | 0.61 | 0.61 | 0.75 | 0.84 | 0.81 | 0.83 |
Inventory Turnover | 1.22 | 1.20 | 1.20 | 1.26 | 1.29 | 1.24 |
Quick Ratio | 0.64 | 0.54 | 0.53 | 0.62 | 0.67 | 0.65 |
Current Ratio | 0.87 | 0.80 | 0.74 | 0.82 | 0.90 | 0.86 |
Return on Equity (ROE) | 59.81% | 60.70% | 80.77% | 88.07% | 72.00% | 71.24% |
Return on Assets (ROA) | 18.73% | 17.43% | 22.26% | 23.55% | 21.69% | 21.81% |
Return on Invested Capital (ROIC) | 39.22% | 42.60% | 68.23% | 88.56% | 73.42% | 67.98% |
Return on Capital Employed (ROCE) | 45.40% | 43.00% | 56.00% | 72.30% | 62.80% | 62.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.35% | 7.09% | 3.64% | 2.69% | 2.62% | 2.85% |
FCF Yield | 6.09% | 4.08% | 2.66% | 2.67% | 3.15% | 2.90% |
Dividend Yield | 4.16% | 3.77% | 1.97% | 1.47% | 1.46% | 1.58% |
Payout Ratio | 44.64% | 50.53% | 43.71% | 37.96% | 45.57% | 45.05% |
Buyback Yield / Dilution | 0.14% | 0.34% | 0.71% | 1.10% | 1.34% | 1.58% |
Total Shareholder Return | 4.30% | 4.11% | 2.67% | 2.56% | 2.80% | 3.16% |